GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Cash Received from Insurance Activities

Dali Pharmaceutical Co (SHSE:603963) Cash Received from Insurance Activities


View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Dali Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Executives
Wu Pei Rong senior management
Yang Jun Xiang Directors, senior managers
Yang Jun Wei Director